Page last updated: 2024-11-02

phenoxybenzamine and Sclerema Neonatorum

phenoxybenzamine has been researched along with Sclerema Neonatorum in 1 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Sclerema Neonatorum: A severe, sometimes fatal, disorder of adipose tissue occurring chiefly in preterm or debilitated infants suffering from an underlying illness and manifested by a diffuse, nonpitting induration of the affected tissue. The skin becomes cold, yellowish, mottled, and inflexible.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamada, K1
Shirahata, A1
Meguro, T1

Other Studies

1 other study available for phenoxybenzamine and Sclerema Neonatorum

ArticleYear
The effects of an alpha blocking agent on the respiratory distress syndrome with disseminated intravascular coagulation in the newborn infants and experimental animals.
    Thrombosis research, 1976, Volume: 8, Issue:2 suppl

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Coagulation; Disseminated Intravascular Coagulation; Fe

1976